Page last updated: 2024-11-08

altholactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

altholactone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID442513
CHEMBL ID512401
CHEBI ID5522
MeSH IDM0430373

Synonyms (13)

Synonym
65408-91-5
altholactone
C09930 ,
chebi:5522 ,
CHEMBL512401 ,
AC1L9CZK ,
(2r,3r,3as,7as)-3-hydroxy-2-phenyl-2,3,3a,7a-tetrahydrofuro[3,2-b]pyran-5-one
zinc04098425
DTXSID90331855
altholactone, >=95% (lc/ms-elsd)
AKOS032948434
FS-9444
Q27106790

Research Excerpts

Treatment

Treatment with altholactone resulted in a significant reduction in cell viability, induction of apoptosis and generation of reactive oxygen species (ROS) in T24 cells. Althlactone treatment was also found to result in a loss of mitochondrial membrane potential, Bcl-2 downregulation and caspase-3 activation.

ExcerptReferenceRelevance
"Altholactone treatment was also found to result in a significant loss of mitochondrial membrane potential, Bcl-2 downregulation and caspase-3 activation."( Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression.
Li, X; Zhao, B, 2014
)
2.57
"Treatment with altholactone resulted in a significant reduction in cell viability, induction of apoptosis and generation of reactive oxygen species (ROS) in T24 cells."( Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression.
Li, X; Zhao, B, 2014
)
2.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
furopyranAny organic heterobicyclic compound containing ortho-fused furan and pyran rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID460116Cytotoxicity against human MCF12A cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL.
AID756422Cytotoxicity against human MCF10A cells up to 100 uM after 20 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756427Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced IL-1beta mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756421Cytotoxicity against human MDA-MB-231 cells up to 100 uM after 20 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756424Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced IL-6 mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756435Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756425Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced G-CSF mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756418Cytotoxicity against human PC3 cells up to 100 uM after 20 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID460117Antiproliferative activity against human CEM cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL.
AID460123Cytotoxicity against human CEM cells assessed as viable cells at 120 uM after 24 hrs by Annexin-V-FITC and porpidium iodide staining based flow cytometry2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL.
AID713894Antimycobacterial activity against Mycobacterium tuberculosis H37Ra2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID756432Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced iNOS expression at 5 uM after 4 hrs by Western blot analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID380842Cell cycle arrest in mouse L1210 cells by accumulation at G2M phase after 21 hrs relative to control1999Journal of natural products, Aug, Volume: 62, Issue:8
Semisynthesis and cytotoxicity of styryl-lactone derivatives.
AID756431Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced COX2 expression at 5 uM after 4 hrs by Western blot analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID460121Cytotoxicity against human CEM cells assessed as late apoptotic/necrotic cells at 120 uM after 24 hrs by Annexin-V-FITC and porpidium iodide staining based flow cytometry2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL.
AID756430Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced iNOS mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756420Cytotoxicity against human MCF7 cells up to 100 uM after 20 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID460115Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL.
AID756419Cytotoxicity against human LNCAP cells up to 100 uM after 20 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756423Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced IFN-beta mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756433Inhibition of LPS-induced NF-kappaB activation in mouse RAW264.7 cells assessed as reduction of IkappaBalpha phosphorylation at 1.5 to 12 uM after 4 hrs by Western blot analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756434Inhibition of LPS-induced NF-kappaB activation in mouse RAW264.7 cells after 18 hrs by luciferase assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756429Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced COX2 mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756428Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced IP-10 mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID380841Cytotoxicity against mouse L1210 cells after 48 hrs by MTT assay1999Journal of natural products, Aug, Volume: 62, Issue:8
Semisynthesis and cytotoxicity of styryl-lactone derivatives.
AID460122Cytotoxicity against human CEM cells assessed as early apoptotic cells at 120 uM after 24 hrs by Annexin-V-FITC and porpidium iodide staining based flow cytometry2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Apoptotic activities in closely related styryllactone stereoisomers toward human tumor cell lines: Investigation of synergism of styryllactone-induced apoptosis with TRAIL.
AID756436Cytotoxicity against mouse RAW264.7 cells after 18 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
AID756426Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction of LPS-induced MCP1 mRNA expression by quantitative real-time PCR analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
(+)-Altholactone exhibits broad spectrum immune modulating activity by inhibiting the activation of pro-inflammatory cytokines in RAW 264.7 cell lines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.00)18.2507
2000's5 (25.00)29.6817
2010's13 (65.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.41 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.27 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]